Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010737 |
---|---|
Receipt number | R000012543 |
Scientific Title | Phase II Study for Efficacy and Safety of nab-paclitaxel for Previously Treated Advanced Non-small Cell Lung Cancer |
Date of disclosure of the study information | 2013/05/16 |
Last modified on | 2019/04/12 12:53:40 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/05/16 10:45:23 | ||
2 | Update | 2013/05/16 19:26:22 | Date of disclosure of the study information |
|
3 | Update | 2013/05/16 19:30:22 | Acronym |
|
4 | Update | 2014/03/08 13:03:38 | Email |
|
5 | Update | 2016/04/01 15:10:27 | Name of primary person or sponsor Organization |
|
6 | Update | 2016/04/07 23:32:32 | Name of primary person or sponsor Organization |
|
7 | Update | 2016/11/17 18:24:23 | Key inclusion criteria |
|
8 | Update | 2018/05/20 10:01:33 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
9 | Update | 2019/03/21 22:38:33 | Recruitment status Date of IRB |
|
10 | Update | 2019/03/21 22:39:45 | Date of IRB |
|
11 | Update | 2019/03/22 11:25:32 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
12 | Update | 2019/03/22 11:26:21 | Number of participants that the trial has enrolled |
|
13 | Update | 2019/04/12 12:53:40 | Recruitment status |